Propionic Acid

Propionic Acid

SCHEMBL4159927

CCC(=O)O.O=C(c1ccccc1)c1ccc2[nH]c(=O)c3[nH]ccc3c2c1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.40
HCRTR1 O43613 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
LIMK1 P53667 1/20 0.39
LIMK2 P53671 1/20 0.39
BRD4 O60885 1/20 0.39
HPGD P15428 3/20 0.38
POLB P06746 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4169905 0.87 KIF11 (0.45) ALDH1A1RAB9ASMN1; SMN2KDM4EMEN1
Propionic Acid SCHEMBL4153840 0.84 PIM1 (0.44) ALDH1A1KDM4EMEN1MAPTKMT2A
Propionic Acid SCHEMBL4171736 0.84 PARP1 (0.41) ALDH1A1RAB9ASMN1; SMN2KDM4EMEN1
Propionic Acid SCHEMBL4161934 0.84 KDM4E (0.41) ALDH1A1RAB9ASMN1; SMN2KDM4EMEN1
Propionic Acid SCHEMBL4160296 0.83 GRM5 (0.44) RAB9ASMN1; SMN2MAPTLIMK1LIMK2
Propionic Acid SCHEMBL4171576 0.82 PIM1 (0.46) ALDH1A1RAB9AKDM4EMEN1MAPT
Propionic Acid SCHEMBL3245762 0.82 BRD4 (0.63) ALDH1A1RAB9ASMN1; SMN2MEN1MAPT
Propionic Acid SCHEMBL4155437 0.81 PPARG (0.46) ALDH1A1KDM4EMEN1MAPTKMT2A
Propionic Acid SCHEMBL4160624 0.81 MPO (0.43) KDM4EPIM1
Propionic Acid SCHEMBL4169911 0.81 GABRA1 (0.41) ALDH1A1KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 ALDH1A1 3830/4885RAB9A 2269/4885SMN1; SMN2 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.